AdaptHealth Corp. (AHCO) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

17/25

Growth 4 Margin 2 Expansion 5 Platform 3 Financial 3

latest quarter score

Earnings Reports

17
AdaptHealth (AHCO) Q2 2026: Portfolio Pruning Drives 16% Organic Growth, Margin Reset on $40M West Coast Drag
August 04, 2026
19
AdaptHealth (AHCO) Q1 2026: Capitated Revenue Surges to 9.2% of Mix, Driving Margin Reset
May 05, 2026
22
AdaptHealth (AHCO) Q4 2025: Capitated Contract Adds 5%–6% Revenue Growth, Reshaping Home Medical Model
February 25, 2026
20
AdaptHealth (AHCO) Q3 2025: Organic Growth Hits 5.1% as Capitated Contracts Reshape Home Care Model
November 04, 2025
18
AdaptHealth (AHCO) Q2 2025: $1B Capitated Deal to Lift Recurring Revenue to 10%
August 05, 2025
14
AdaptHealth (AHCO) Q1 2025: Respiratory Outpaces as $25M Debt Cut Sharpens Focus on Core Growth
July 06, 2025
AdaptHealth (AHCO) Q3 2024: Diabetes Revenue Down $45M as Operational Reset Delays Segment Recovery
November 05, 2024
AdaptHealth (AHCO) Q2 2024: Sleep Revenue Climbs 6.5% as Portfolio Simplification and Tech Investments Accelerate
August 06, 2024
AdaptHealth (AHCO) Q1 2024: EBITDA Margin Expands 200bps as Supply Chain and Diabetes Execution Drive Upside
May 07, 2024
AdaptHealth (AHCO) Q4 2023: Sleep Resupply Census Hits 1.55 Million, Driving Margin Expansion
February 27, 2024
17
AdaptHealth (AHCO) Q3 2023: Sleep Revenue Jumps 17% as Humana Transition Delays Margin Lift
November 07, 2023
AdaptHealth (AHCO) Q2 2023: Sleep and Respiratory Revenue Up 15%, Offsetting Diabetes Headwinds
August 08, 2023
ADAPT Health (AHCO) Q1 2023: Sleep Census Jumps 53% as Diabetes Channel Shift Compresses Margins
May 09, 2023
AdaptHealth (AHCO) Q4 2022: Sleep Patient Census Hits New High as Diabetes Growth Slows to Low Teens
February 28, 2023

Browse all companies